doxazosin

Generic: doxazosin mesylate

Labeler: northwind health company, llc
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name doxazosin
Generic Name doxazosin mesylate
Labeler northwind health company, llc
Dosage Form TABLET
Routes
ORAL
Active Ingredients

doxazosin mesylate 4 mg/1

Manufacturer
Northwind Health Company, LLC

Identifiers & Regulatory

Product NDC 51655-130
Product ID 51655-130_48c3dac9-f8ec-a42e-e063-6294a90a87fa
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA209013
Marketing Start 2023-02-27
Marketing End 2027-08-31

Pharmacologic Class

Classes
adrenergic alpha-antagonists [moa] alpha-adrenergic blocker [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 51655130
Hyphenated Format 51655-130

Supplemental Identifiers

RxCUI
197627
UNII
86P6PQK0MU

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name doxazosin (source: ndc)
Generic Name doxazosin mesylate (source: ndc)
Application Number ANDA209013 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 4 mg/1
source: ndc
Packaging
  • 90 TABLET in 1 BOTTLE, PLASTIC (51655-130-26)
  • 30 TABLET in 1 BOTTLE, PLASTIC (51655-130-52)
source: ndc

Packages (2)

51655-130-26 90 TABLET in 1 BOTTLE, PLASTIC (51655-130-26) 51655-130-52 30 TABLET in 1 BOTTLE, PLASTIC (51655-130-52)

Ingredients (1)

doxazosin mesylate (4 mg/1)

Linked Drug Pages (1)

Doxazosin ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "48c3dac9-f8ec-a42e-e063-6294a90a87fa", "openfda": {"unii": ["86P6PQK0MU"], "rxcui": ["197627"], "spl_set_id": ["f6c9856e-9154-f349-e053-6294a90a9f2c"], "manufacturer_name": ["Northwind Health Company, LLC"]}, "finished": true, "packaging": [{"sample": false, "description": "90 TABLET in 1 BOTTLE, PLASTIC (51655-130-26)", "package_ndc": "51655-130-26", "marketing_end_date": "20270831", "marketing_start_date": "20230718"}, {"sample": false, "description": "30 TABLET in 1 BOTTLE, PLASTIC (51655-130-52)", "package_ndc": "51655-130-52", "marketing_end_date": "20270831", "marketing_start_date": "20230227"}], "brand_name": "Doxazosin", "product_id": "51655-130_48c3dac9-f8ec-a42e-e063-6294a90a87fa", "dosage_form": "TABLET", "pharm_class": ["Adrenergic alpha-Antagonists [MoA]", "alpha-Adrenergic Blocker [EPC]"], "product_ndc": "51655-130", "generic_name": "Doxazosin Mesylate", "labeler_name": "Northwind Health Company, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Doxazosin", "active_ingredients": [{"name": "DOXAZOSIN MESYLATE", "strength": "4 mg/1"}], "application_number": "ANDA209013", "marketing_category": "ANDA", "marketing_end_date": "20270831", "marketing_start_date": "20230227"}